Story continues below

Item 8.01. Other Events.

On May11, 2017, the Board of Directors of Bruker Corporation (the
Company) approved a share repurchase program authorizing the
purchase of up to $225 million of the Companys common stock over
a two-year period commencing May12, 2017 and declared a quarterly
cash dividend in the amount of $0.04 per share on the Companys
common stock. The dividend will be paid on June23, 2017 to
stockholders of record as of June5, 2017.

Under the share repurchase program, the Company may repurchase
its common stock from time to time, in amounts, at prices, and at
such times as the Company deems appropriate, subject to market
conditions, legal requirements and other considerations. The
Companys repurchases may be executed using open market purchases,
privately negotiated purchases or other transactions during the
period from May12, 2017 to May11, 2019. The Company intends to
fund repurchases under the share repurchase program from cash on
hand and available borrowings under its existing credit facility.
The share repurchase program does not obligate the Company to
repurchase any specific number of shares and may be suspended,
modified or terminated at any time without prior notice.

A copy of the Companys press release announcing approval of the
$225 million share repurchase program and the quarterly dividend
payment is attached as Exhibit99.1 to this Current Report on


This report contains forward-looking statements, including, but
not limited to, statements regarding the Companys commitment to
repurchasing its shares at any level in the future, the
anticipated value of shares to be repurchased by the Company, the
expected timing of such repurchases and the availability of funds
for the repurchase of shares. These forward-looking statements
are based on current information and expectations, and involve a
number of risks and uncertainties. Actual future results and/or
events may differ materially from such expectations as a result
of important risk factors, which include, in addition to those
identified in the Companys Form10-K for the year ended
December31, 2016 and its other filings with the Securities and
Exchange Commission: a change in the Companys share repurchase
program by the Companys Board of Directors or management,
including changes in the value of shares to be repurchased or the
timing of such repurchases, and unanticipated material payment
obligations incurred by the Company that decrease the Companys
willingness or ability to repurchase shares at the anticipated
level and timing, or at all. These risks and uncertainties could
cause actual results to differ materially from those referred to
in these forward-looking statements. The Company expressly
disclaims any obligation to update or revise these
forward-looking statements, except as otherwise specifically
stated by the Company or as required by law or regulation.

Section9 Financial Statements and Exhibits

Item 9.01. Financial Statements and Exhibits.




99.1 Press release dated May12, 2017.


Bruker Corporation is a designer and manufacturer of scientific instruments, and analytical and diagnostic solutions. The Company’s operating segments include the Bruker BioSpin Group; the Bruker Chemicals, Applied Markets, Life Science, In-Vitro Diagnostics, Detection (CALID) Group; the Bruker Nano Group, and the Bruker Energy & Supercon Technologies (BEST) Segment. The Bruker BioSpin Group segment designs, manufactures and distributes enabling life science tools. The Bruker CALID segment designs, manufactures and distributes life science mass spectrometry instruments that can be integrated and used along with other sample preparation or chromatography instruments, as well as chemical, biological, radiological, nuclear and explosive (CBRNE) detection products. The Bruker Nano segment designs, manufactures and distributes spectroscopy and microscopy instruments. The BEST segment develops and manufactures superconducting and non-superconducting materials and devices.


BRUKER CORPORATION (NASDAQ:BRKR) closed its last trading session down -0.34 at 25.33 with 490,419 shares trading hands.

An ad to help with our costs